CytomX Therapeutics, Inc. (CTMX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:01AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 117.18M |
| Enterprise Value | -43.36M |
| Trailing P/E | N/A |
| Forward P/E | 43.29 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.26 |
| Price/Book (mrq) | 5.04 |
| Enterprise Value/Revenue | -0.43 |
| Enterprise Value/EBITDA | 10.06 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.02 |
| 52-Week Change 3 | 4.85% |
| S&P500 52-Week Change 3 | 21.23% |
| 52 Week High 3 | 2.8550 |
| 52 Week Low 3 | 1.0400 |
| 50-Day Moving Average 3 | 2.0236 |
| 200-Day Moving Average 3 | 1.6059 |
Share Statistics
| Avg Vol (3 month) 3 | 924.01k |
| Avg Vol (10 day) 3 | 667.2k |
| Shares Outstanding 5 | 67.73M |
| Implied Shares Outstanding 6 | 67.73M |
| Float 8 | 53.82M |
| % Held by Insiders 1 | 1.19% |
| % Held by Institutions 1 | 48.56% |
| Shares Short (Mar 28, 2024) 4 | 3.32M |
| Short Ratio (Mar 28, 2024) 4 | 2.17 |
| Short % of Float (Mar 28, 2024) 4 | 4.95% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 4.91% |
| Shares Short (prior month Feb 29, 2024) 4 | 1.64M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -0.56% |
| Operating Margin (ttm) | -2.28% |
Management Effectiveness
| Return on Assets (ttm) | -1.75% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 101.21M |
| Revenue Per Share (ttm) | 1.37 |
| Quarterly Revenue Growth (yoy) | 32.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | -4.31M |
| Net Income Avi to Common (ttm) | -569k |
| Diluted EPS (ttm) | -0.0100 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 174.51M |
| Total Cash Per Share (mrq) | 2.58 |
| Total Debt (mrq) | 13.97M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.17 |
| Book Value Per Share (mrq) | -0.70 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -56.03M |
| Levered Free Cash Flow (ttm) | 43.66M |
© 2024 Yahoo. All rights reserved.